Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7417 p299-303
9 September 2006

This section
Reprint   Photocopy

PDF 130K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: BPC news (299/300)  |  301   302   303

299 Minister launches national framework to support establishment of pharmacists with special interests A national framework and guidance to support the establishment of pharmacists with special interests (PhwSIs) was launched by minister of state for delivery and quality, Andy Burnham, at the 2006 British Pharmaceutical Conference in Manchester this week
PJ 2006;277:299
Full Text

299 Support for closer working with GPs to manage long-term conditions Support for pharmacists wishing to contribute to the care of patients with long-term conditions comes in a document launched at the British Pharmaceutical Conference in Manchester this week
PJ 2006;277:299
Full Text

299 Regulator and leadership body do not need to be within same organisation, says Keith Ridge There needs to be a close understanding between the profession's leadership body and the profession's regulator but the two do not need to be part of the same organisation, Keith Ridge, chief pharmaceutical officer for England, said during a debate held at the British Pharmaceutical Conference in Manchester earlier this week
PJ 2006;277:299
Full Text


300 Commissioning needs to be informed by strategic pharmaceutical advice, says Society's President Commissioning of NHS services has to be informed by strategic pharmaceutical advice and medicines management expertise if it is to be fully effective, Hemant Patel, President of the Royal Pharmaceutical Society, told health minister Andy Burnham in his address to the 2006 British Pharmaceutical Conference held in Manchester earlier this week
PJ 2006;277:300
Full Text

300 Push for enhanced services “must come from you”, pharmacists told Now is the time to push enhanced services, Andy Burnham, minister of state for delivery and quality, told participants at the 2006 British Pharmaceutical Conference in Manchester this week
PJ 2006;277:300
Full Text

300 Bradford professor receives Harrison Memorial Medal Peter York, professor of physical pharmaceutics at the University of Bradford and a fellow of the Royal Pharmaceutical Society, was awarded the Harrison Memorial Medal at the British Pharmaceutical Conference this week
PJ 2006;277:300
Full Text

300 News in brief Section 60 Order on horizon / Review of CPPE
PJ 2006;277:300
Full Text

301 Changes to homoeopathic remedy licensing announced by MHRA New rules, to be introduced by the Medicines and Healthcare products Regulatory Agency, will create a more level market in homoeopathic remedies
PJ 2006;277:301
Full Text

301 PSNC reveals underpayment of pharmacies Checks of the accuracy of prescription pricing by the NHS in England showed that contractors were paid on average 0.05 per cent less than they were due in the past financial year
PJ 2006;277:301
Full Text

301 CHRE highlights information barriers faced by the Society Regulatory difficulties faced by the Royal Pharmaceutical Society in two areas have been highlighted by the Council for Healthcare Regulatory Excellence
PJ 2006;277:301
Full Text

301 Department appoints new director general of workforce Clare Chapman, currently group personnel director at Tesco, has been appointed director general of workforce for the NHS and social care at the Department of Health
PJ 2006;277:301
Full Text

301 Boots joins National Pharmacy Association Boots The Chemists will be joining the National Pharmacy Association
PJ 2006;277:301
Full Text

301 Alliance Boots moves forward with its expansion in Ireland Alliance Boots is to open 30 new stores across the Irish Republic over the next five years, in a €50m expansion programme. By 2011, it aims to have more than 70 outlets in the country
PJ 2006;277:301
Full Text

301 NICE to tackle practices that persist without evidence base The National Institute for Health and Clinical Excellence will begin a new programme to help the NHS to reduce the amount of money spent on treatments that lack a sound evidence base, the Department of Health has announced this week
PJ 2006;277:301
Full Text


302 NPSA recommends anticoagulant role for pharmacy Pharmacists could play a greater role in the provision of anticoagulant care, new recommendations from the National Patient Safety Agency and the British Committee for Standards in Haematology suggest
PJ 2006;277:302
Full Text

302 MHRA seeks new advisers Experts in clinical pharmacology are among those being asked to apply for new positions on the independent scientific advisory committee (ISAC) for the Medicines and Healthcare products Regulatory Agency database research
PJ 2006;277:302
Full Text

302 Community pharmacy wins PCT contract to supply aseptic products for palliative care Manor Pharmacy — a 46 strong community pharmacy multiple in the East Midlands — has won a contract from Erewash Primary Care Trust to prepare and supply pre-filled syringes of medicines for use in palliative care
PJ 2006;277:302
Full Text

302 Pharmacists can help asthma management Community pharmacists can help people with asthma better manage their condition, Australian research presented in two abstracts at the European Respiratory Society congress in Munich this week has shown
PJ 2006;277:302
Full Text


303 Further ASCOT data support case for amlodipine-based therapy Patients receiving calcium channel blocker-based antihypertensive therapy are less likely to develop new-onset diabetes than those receiving beta-blocker-based therapy, according to a reanalysis of data from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) presented at the World Congress of Cardiology in Barcelona this week
PJ 2006;277:303
Full Text

303 New data provide metabolic syndrome insight Patients with both coronary heart disease and metabolic syndrome are good candidates for intensive lipid-lowering therapy, according the authors of a study
PJ 2006;277:303
Full Text

303 Vaccination could reduce cervical cancer cases by 76 per cent Prophylactic vaccination against human papillomavirus (HPV) could achieve a 76 per cent reduction in the prevalence of cervical cancer, a modelling study presented at the International Papillomavirus Conference in Prague this week has shown
PJ 2006;277:303
Full Text

Back to Top


©The Pharmaceutical Journal